$17.62
-0.92 (-4.96%)
Performance
1D
—
1W
+5.57%
1M
+10.33%
3M
-33.51%
6M
-4.55%
1Y
-3.21%
YTD
-4.76%
Open$18.56
Previous Close$18.54
Day High$18.79
Day Low$17.37
52W High$27.31
52W Low$14.00
Volume—
Avg Volume2.39M
Market Cap3.10B
P/E Ratio—
EPS$-3.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.04
Below
SMA 200
$19.33
Below
RSI (14)
72.2
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+455.4% upside
Current
$17.62
$17.62
Target
$97.86
$97.86
$76.65
$97.86 avg
$132.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 618.44M | 584.19M | 668.57M |
| Net Income | 86.92M | 95.40M | 98.23M |
| Profit Margin | 14.1% | 16.3% | 14.7% |
| EBITDA | 124.54M | 120.89M | 157.55M |
| Free Cash Flow | 66.24M | 92.85M | 89.99M |
| Rev Growth | +16.5% | -3.4% | +9.6% |
| Debt/Equity | 0.27 | 0.23 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |